DROPIT Trial
Optimising the prescription of Proton Pump Inhibitors - DROPIT: a randomized clinical trial in the Swiss primary care setting
Research question
Proton pump inhibitors (PPIs) are the most common treatment of gastric acid-related disorders, and their use is increasing. It can sometimes happen that these treatments are used for longer than necessary, or at higher than required doses.
The DROPIT study aims to evaluate an intervention to optimise the prescription of PPIs in the Swiss primary care setting.
Are you a general practitioner (Hausarzt oder Hausärztin) in the German-speaking part of Switzerland and would like to join the trial? More info here:
Overview
| Project leader | Prof. Dr. med. Dr. phil. Sven Streit Prof. Dr. phil. Jennifer Inauen |
|
|---|---|---|
| Project core group | PD Dr. med. Pascal Juillerat Dr. phil. Michaela Barbier Prof. Dr. phil. Sofia Carolina Zambrano Ramos Dr. sc. Enriqueta Vallejo-Yagüe Dr. phil. Katharina Jungo Dr. phil. Kristie Weir Dr. med. Martina Zangger Renata Lüthold Dr. phil. Angela Schulthess Clémentine Tombez Yvonne Mattmann |
|
| Partner(s) | Dr. phil. Samantha Chan Jenal Flurina Dr. phil. Marie Roumet Nadine Uebersax |
|
| Project Advisory Board | PD Dr. Sven Trelle Prof. Nicolas Rodondi Prof. Barbara Farrell Dr. Carole Aubert Prof. Doug Bauer Dr. Jean-Pascal Fournier Prof. Jeremy Grimshaw Prof. Tijn Kool Prof. S. Neuner-Jehle Prof. Edoardo Savarino Prof. Alain Schoepfer Prof. M. Schwenkglenks Prof. Oliver Senn Prof. Anne Spinewine Prof. David Schwappach |
|
| Project Stakeholders | Isabelle Viva Dr. Andrea Schindler Nithaya Nothum Dr. Bartek Niznik Julia Wyss |
|
| Funder(s) | Swiss National Science Foundation, Investigator initiated clinical trials (IICT)
|
|
| Study design | Cluster-randomized clinical trial | |
| Study start |
2023 |
|
| External links |
|